AI scans liver cancer to predict patient survival
NCT ID NCT07479264
Summary
This study looked at whether doctors could use MRI scans and artificial intelligence (AI) to predict how patients with a specific type of liver cancer (intrahepatic cholangiocarcinoma) would fare after surgery. Researchers analyzed MRI scans from 169 patients to see if certain features in the tumor could predict survival and cancer recurrence over five years. The goal was to find non-invasive ways to better understand a patient's prognosis before surgery.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INTRAHEPATIC CHOLANGIOCARCINOMA (ICC) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The First Affiliated Hospital, Sun Yat-sen University
Guangzhou, Guangdong, 510080, China
Conditions
Explore the condition pages connected to this study.